Zurcher Kantonalbank (Zurich Cantonalbank) Allovir, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$6.75 - $13.52 $8,903 - $17,832	-1,319 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$12.94 - $25.99 $1,785 - $3,586	-138 Reduced 9.47%	1,319 $17,000
Q3 2021 Nov 15, 2021	SELL	$16.97 - $25.06 $67 - $100	-4 Reduced 0.27%	1,457 $37,000
Q2 2021 Jul 30, 2021	BUY	$19.44 - $25.06 $1,846 - $2,380	95 Added 6.95%	1,461 $29,000
Q1 2021 May 03, 2021	BUY	$20.81 - $45.5 $28,426 - $62,153	1,366 New	1,366 $32,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$4.97 Million
0.4% of portfolio
Octagon Capital Advisors LP New York, NY

11.2M
Shares

$4.93 Million
2.19% of portfolio
Siren, L.L.C. New York, NY

6.6M
Shares

$2.9 Million
0.27% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.28M
Shares

$1.45 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$1.16 Million
0.0% of portfolio

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account